Division of HIV, ID, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
AIDS Patient Care STDS. 2021 May;35(5):188-193. doi: 10.1089/apc.2020.0244. Epub 2021 Apr 22.
HIV-related stigma is a known barrier to retention in care. However, no large-scale, multi-site studies have prospectively evaluated the effect of internalized stigma on retention in care. The Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort study integrates medical record and survey data from people living with HIV (PLWH) seen in HIV primary care clinics across the United States, and assesses internalized stigma yearly using a validated 4-item Likert scale. We used multivariable logistic regression models to evaluate associations between mean internalized stigma and two prospective retention in care outcomes: keeping the next primary care appointment and keeping all scheduled primary care appointments in the 12 months following stigma assessment. From February 2016 to November 2017, 5968 PLWH completed the stigma assessment and had adequate follow-up time. Mean stigma was 1.9 (standard deviation 1.08). Increased mean stigma scores were associated with decreased odds of attending the next primary care appointment [adjusted odds ratio (aOR) = 0.93, 95% confidence interval (CI) 0.88-0.99, = 0.02], and all primary care appointments in the subsequent 12 months (aOR = 0.94, 95% CI 0.89-0.99, = 0.02). In both models, younger age and Black race were also independently associated with suboptimal appointment attendance. There was no support for interactions between internalized stigma and covariates. Internalized HIV stigma had an independent negative effect on the odds of subsequent appointment attendance. This study highlights the importance of identifying even low levels of internalized stigma. Interventions to address internalized HIV stigma are critical to supporting retention in care and improving clinical outcomes.
艾滋病毒相关耻辱感是导致患者无法坚持接受治疗的已知障碍。然而,目前还没有大规模、多地点的研究前瞻性地评估内化耻辱感对坚持接受治疗的影响。艾滋病研究中心综合临床系统网络(CNICS)队列研究整合了美国各地艾滋病毒初级保健诊所中接受治疗的艾滋病毒感染者(PLWH)的病历和调查数据,并使用经过验证的 4 项李克特量表每年评估内化耻辱感。我们使用多变量逻辑回归模型来评估平均内化耻辱感与两个前瞻性保留治疗结果之间的关联:保留下一次初级保健预约和在耻辱感评估后 12 个月内保留所有预定的初级保健预约。从 2016 年 2 月到 2017 年 11 月,5968 名 PLWH 完成了耻辱感评估,并具有足够的随访时间。平均耻辱感为 1.9(标准差 1.08)。平均耻辱感得分增加与参加下一次初级保健预约的几率降低相关[调整后的优势比(aOR)=0.93,95%置信区间(CI)0.88-0.99,=0.02],以及在随后的 12 个月内所有初级保健预约[aOR=0.94,95%置信区间(CI)0.89-0.99,=0.02]。在这两个模型中,年龄较小和黑人种族也与预约出席情况不佳独立相关。内化耻辱感与协变量之间没有交互作用的支持。内化的艾滋病毒耻辱感对随后预约出席的几率有独立的负面影响。这项研究强调了识别即使是低度内化耻辱感的重要性。解决内化艾滋病毒耻辱感的干预措施对于支持坚持接受治疗和改善临床结果至关重要。